Daxor Corporation (DXR) Stock: Heading For The Top On Clinical News

Daxor Corporation (NYSEAMERICAN: DXR) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced a clinical update, showing overwhelmingly strong efficacy surrounding its BVA-100 blood volume analyzer. Today, we’ll talk about: The clinical data that was released; what we’re seeing from DXR as a result; and … Read more

Daxor (DXR) Stock: Here’s Why It’s Soaring

Daxor Corporation¬†(NYSEAMERICAN: DXR) is having yet another incredible start to the trading session in the pre-market hours this morning, expanding on recent and robust gains that we’ve seen on the stock. Ultimately, the gains were the result of a recent announcement explaining the presentation of new data. Today, we’ll talk about the presentation, what we’re … Read more